Annette North

Insider Reports History

Entity
Individual
Location
C/O Sgx Pharmaceuticals, Inc., 10505 Roselle Street, San Diego, CA
Signature
/s/ Paolo Tombesi, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Annette North:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Turning Point Therapeutics, Inc. EVP & General Counsel Common Stock 28K $2.13M $76.00 Feb 9, 2022 Direct
Turning Point Therapeutics, Inc. EVP & General Counsel Stock Option (right to buy) 58.6K Feb 9, 2022 Direct

Insider Reports Filed by Annette North

Symbol Company Period Transactions Value $ Form Type Date Filed Role
TPTX Turning Point Therapeutics, Inc. Feb 9, 2022 3 -$24.3K 4 Feb 11, 2022 EVP & General Counsel
TPTX Turning Point Therapeutics, Inc. Aug 30, 2021 3 -$630K 4 Aug 31, 2021 EVP, General Counsel & Secty.
TPTX Turning Point Therapeutics, Inc. Jun 15, 2021 5 -$900K 4 Jun 16, 2021 EVP, General Counsel & Secty.
TPTX Turning Point Therapeutics, Inc. May 6, 2021 2 $100K 4 May 7, 2021 EVP, General Counsel & Secty.